Sign Up
bf/NYSE:RCUS_icon.jpeg

COM:ARCUSBIO

Arcus Biosciences

  • Stock

USD

Last Close

14.28

22/11 21:00

Market Cap

1.27B

Beta: -

Volume Today

534.33K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.01
-
0.03
309.59%
0.07
143.07%
0.10
35.91%
0.24
139.63%
0.08
65.38%
0.11
28.31%
cash conversion cycle
-256.79
-
cash per share
4.03
-
4.13
2.53%
7.41
79.47%
4.30
42.03%
13.30
209.52%
7.21
45.81%
18.42
155.61%
10.26
44.31%
company equity multiplier
1.10
-
1.24
12.24%
1.17
5.48%
1.24
5.94%
1.54
24.02%
1.89
23.05%
2.05
8.21%
2.37
15.78%
days of inventory outstanding
days of payables outstanding
387.81
-
days of sales outstanding
6.46
-
3.63
43.84%
3.21
11.44%
8.00
148.92%
711.94
8,804.54%
140.13
80.32%
131.03
6.50%
dividend yield
ebit per revenue
-37.82
-
-6.57
82.64%
-5.91
9.95%
-1.60
72.90%
0.14
108.84%
-2.50
1,864.50%
-2.91
16.24%
ebt per ebit
0.99
-
0.99
0.50%
0.90
8.99%
0.95
5.63%
0.99
3.56%
1.01
1.86%
0.95
5.69%
0.89
6.81%
effective tax rate
-0.11
-
0.10
197.62%
0.05
51.45%
0.03
33.98%
-0.00
111.32%
-0.02
430.23%
enterprise value multiple
-20.88
-
-12.29
41.13%
-5.38
56.24%
-4.34
19.40%
-10.13
133.54%
50.52
598.78%
-3.51
106.95%
-4.46
26.97%
fixed asset turnover
0.13
-
0.75
497.70%
1.61
113.78%
3.29
104.41%
2.79
15.22%
3.20
14.85%
2.29
28.31%
free cash flow per share
-0.69
-
-0.72
3.52%
-1.35
87.91%
-1.72
27.41%
1.97
214.69%
-4.07
306.44%
7.78
290.91%
-4.46
157.35%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
0.86
13.68%
interest coverage
-11.15
-
208.65
-
-140
167.10%
-170
21.43%
inventory turnover
long term debt to capitalization
0.03
-
0.12
314.12%
net income per ebt
1
-
1
0%
1
0%
0.90
10.36%
0.95
5.95%
0.97
1.80%
1.00
3.82%
1.02
1.61%
net profit margin
-37.57
-
-5.94
84.20%
-5.06
14.74%
-1.51
70.27%
0.14
109.17%
-2.38
1,827.74%
-2.62
10.07%
operating cash flow per share
-0.53
-
-0.59
11.72%
-1.24
110.89%
-1.68
34.96%
2.03
221.03%
-3.70
282.22%
7.99
316.27%
-4.14
151.72%
operating cycle
131.03
-
operating profit margin
-37.82
-
-6.57
82.64%
-5.91
9.95%
-1.60
72.90%
0.14
108.84%
-2.50
1,864.50%
-2.91
16.24%
payables turnover
0.94
-
pretax profit margin
-37.57
-
-5.94
84.20%
-5.65
4.88%
-1.58
71.94%
0.14
109.00%
-2.38
1,764.10%
-2.57
8.32%
price fair value
4.20
-
4.70
12.01%
1.59
66.24%
2.70
70.24%
2.83
4.83%
3.33
17.68%
1.72
48.26%
3.06
77.40%
receivables turnover
56.52
-
100.64
78.06%
113.64
12.92%
45.65
59.83%
0.51
98.88%
2.60
408.04%
2.79
6.95%
return on assets
-0.16
-
-0.28
70.12%
-0.18
35.27%
-0.37
107.24%
-0.15
59.59%
0.03
121.97%
-0.20
698.17%
-0.28
41.23%
return on capital employed
-0.17
-
-0.30
72.22%
-0.21
29.27%
-0.49
131.25%
-0.19
61.17%
0.04
119.93%
-0.24
738.83%
-0.37
53.55%
return on equity
-0.18
-
-0.34
90.94%
-0.21
38.81%
-0.46
119.55%
-0.23
49.88%
0.06
127.03%
-0.41
747.28%
-0.66
63.51%
total debt to capitalization
0.02
-
0.02
25.10%
0.05
119.74%
0.08
43.85%
0.17
113.40%
0.02
-

All numbers in USD (except ratios and percentages)